The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Second-line treatment of metastatic gastric cancer in the era of predictive biomarkers: A cost-effectiveness analysis.
 
Brianna Lauren
No Relationships to Disclose
 
Elisabeth Silver
Consulting or Advisory Role - Cambridge Biomedical and Economic Consulting Group
 
Myles Ingram
No Relationships to Disclose
 
Aaron Oh
No Relationships to Disclose
 
Lindsay Kumble
No Relationships to Disclose
 
Sassan Ostvar
Consulting or Advisory Role - Cambridge Biomedical and Economic Consulting Group
 
Monika Laszkowska
No Relationships to Disclose
 
Jacqueline N. Chu
No Relationships to Disclose
 
Gulam Abbas Manji
Honoraria - Celgene; Exelixis; Roche/Genentech
Consulting or Advisory Role - Exelixis; Roche/Genentech
Research Funding - Merck (Inst); Plexxikon (Inst); Roche/Genentech (Inst)
Travel, Accommodations, Expenses - Celgene; Exelixis; Roche/Genentech
 
Alfred I. Neugut
Stock and Other Ownership Interests - Stemline Therapeutics
Consulting or Advisory Role - EHE International; Otsuka; Pfizer; Teva; United Biosource Corporation
 
Chin Hur
Stock and Other Ownership Interests - Cambridge Biomedical and Economic Consulting Group
Honoraria - Gilead Sciences; Novo Nordisk